Glucocorticoid Receptor 

 186 Products   186 Products   1696 Diseases   95004 News 


«12...315316317318319320321322323324325...10671068»
  • ||||||||||  Darzalex (daratumumab) / J&J
    Use of Pronase to Identify HLA Crossmatch Antibody Interference (Hynes Halls C & D: Board No. B246) -  May 20, 2022 - Abstract #ATC2022ATC_3015;    
    Antibody-based therapies may interfere with validity of HLA crossmatch testing for solid organ transplant. The use of pronase may be beneficial to distinguish antibody therapy related false-positive crossmatches from true-positive organ incompatibility.
  • ||||||||||  hydrocortisone / Generic mfg.
    Bilateral Renal Autotransplantation for Retroperitoneal Liposarcoma (Hynes Halls C & D: Board No. C182) -  May 20, 2022 - Abstract #ATC2022ATC_2541;    
    The first, is that it provides an improved ability to clear tumor around the kidney potentially with less blood loss. The second is that kidney auto-transplantion moves the kidney from the retroperitoneal location, where many retroperitoneal sarcomas are likely to recur, preventing recurrences from impacting the kidney and potentially making subsequent repeat resections easier if or when needed.
  • ||||||||||  methylprednisolone sodium succinate / Generic mfg.
    Acute Cellular Rejection in Liver Transplant Recipients Following Vaccination Against Covid-19 (Hynes Room 313) -  May 20, 2022 - Abstract #ATC2022ATC_2002;    
    Further study is required to better understand this relationship while closer monitoring following vaccination may be warranted in this patient population. Figure 1: Liver Enzymes of Five Patients Relative to Vaccine Doses Figure 2: Liver Histopathology in Five Patients Showing Acute Cellular Rejection and C4d Staining in One Patient
  • ||||||||||  Ninlaro (ixazomib) / Takeda
    Ixazomib for Desensitization (IXADES): Results of a Phase II Clinical Trial (Hynes Ballroom A) -  May 20, 2022 - Abstract #ATC2022ATC_1918;    
    P2
    * IXADES (IXAzomib for DESensitization) was a pilot exploratory, proof of concept, open-label, single-center phase II clinical trial (NCT03213158) in which highly sensitized (cPRA > 80%) kidney transplant candidates, active on the waitlist for > 24 months were treated with 12 monthly cycles of Ixazomib 3 mg + dexamethasone 20 mg. Ixazomib alone or in combination with other immunosuppressive agents may offer a simple, safe, and effective approach to desensitization strategies in kidney transplantation.
  • ||||||||||  methylprednisolone acetate / Generic mfg.
    Trial completion date, Trial primary completion date:  Ultrasound Guided Platelet Rich Plasma Injections for Post Traumatic Greater Occipital Neuralgia (clinicaltrials.gov) -  May 20, 2022   
    P1,  N=35, Recruiting, 
    Alternate strategies, including booster vaccinations or monoclonal antibody prophylaxis should be studied in this vulnerable population. Trial completion date: Jun 2022 --> Jan 2023 | Trial primary completion date: Feb 2022 --> Jan 2023
  • ||||||||||  Zilretta (triamcinolone acetonide ER) / Pacira
    Trial completion, Trial completion date, Trial primary completion date:  Effect of Zilretta Injection (clinicaltrials.gov) -  May 20, 2022   
    P1,  N=35, Completed, 
    Trial completion date: Jun 2022 --> Jan 2023 | Trial primary completion date: Feb 2022 --> Jan 2023 Recruiting --> Completed | Trial completion date: Sep 2023 --> Jan 2022 | Trial primary completion date: Sep 2023 --> Jan 2022
  • ||||||||||  heparin sodium injection / Generic mfg., dexamethasone injection / Generic mfg.
    Trial completion date, Trial initiation date, Trial primary completion date:  MINECRAFT: Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19 (clinicaltrials.gov) -  May 20, 2022   
    P2,  N=180, Not yet recruiting, 
    Recruiting --> Completed | Trial completion date: Sep 2023 --> Jan 2022 | Trial primary completion date: Sep 2023 --> Jan 2022 Trial completion date: Dec 2022 --> Dec 2023 | Initiation date: Sep 2021 --> Sep 2022 | Trial primary completion date: May 2022 --> May 2023
  • ||||||||||  fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
    Trial completion date, Trial termination, Trial primary completion date:  Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD (clinicaltrials.gov) -  May 20, 2022   
    P4,  N=64, Terminated, 
    Trial primary completion date: Mar 2024 --> Aug 2021 Trial completion date: Dec 2023 --> Apr 2022 | Recruiting --> Terminated | Trial primary completion date: Dec 2022 --> Apr 2022; Adequate number of patients could not be reached in the relevant centers.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  The effect of steroids used in the treatment of coronavirus disease 2019 on infections in intensive care. (Pubmed Central) -  May 19, 2022   
    Reproductive rates among steroid types were determined as 25 (56.8%) in the Methylprednisolone group, 18 (69.2%) (Highest) in the Dexamethasone + Methylprednisolone group, and 54 (43.2%) (Lowest) in the Dexamethasone group...In conclusion, while steroids reduce mortality by controlling the hyper-inflammatory picture, they also increase mortality with increased secondary infections. Preventing infections enables success with steroids.
  • ||||||||||  dexamethasone / Generic mfg., lenalidomide / Generic mfg., carfilzomib / Generic mfg.
    Trial primary completion date:  12-C-0107: Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma (clinicaltrials.gov) -  May 19, 2022   
    P2,  N=55, Active, not recruiting, 
    Preventing infections enables success with steroids. Trial primary completion date: Jun 2023 --> Mar 2022
  • ||||||||||  Decadron (dexamethasone) / Merck (MSD)
    Trial completion date, Trial primary completion date:  Steroids in Total Knee Arthroplasty (clinicaltrials.gov) -  May 19, 2022   
    P4,  N=150, Suspended, 
    Trial primary completion date: Jun 2023 --> Mar 2022 Trial completion date: Jan 2022 --> Apr 2023 | Trial primary completion date: Jan 2022 --> Apr 2023
  • ||||||||||  Cubicin (daptomycin) / Merck (MSD)
    PERSISTENT STAPHYLOCOCCAL BACTEREMIA AFFECTING MULTIPLE SYSTEMS IN A BOY WITH SURGICALLY CORRECTED CONGENITAL HEART DISEASE () -  May 19, 2022 - Abstract #ESPID2022ESPID_1366;    
    Renal involvement was ultimately attributed to immune-mediated damage and IV methylprednisolone(2mg/kg/d) was initiated, with gradual resolution of proteinuria and dose tapering...The patient remained on IV antibiotics for 42 days with slow recovery, and was discharged home on oral cefuroxime for 14 days...Immune-mediated nephritis is not unlikely. In the presence of vascular grafts, it may be prudent to follow an endocarditis treatment regimen, even when not confirmed by imaging techniques.
  • ||||||||||  TICK BORNE ENCEPHALITIS INDUCED ACUTE NECROTIZING ENCEPHALOPATHY OF CHILDHOOD: A CASE REPORT () -  May 19, 2022 - Abstract #ESPID2022ESPID_1362;    
    Gradual improvement was observed, however, at the time of discharge severe neurologic sequelae remained with sensorimotor aphasia, dysphagia, cognitive impairment, asymetric tetraparesis. Learning Points/ Although ANEC is a rare condition, it should be promptly recognized as it may mimic vascular origin ischemic changes in brain, but treatment strategies differ.
  • ||||||||||  remdesivir / Generic mfg., dexamethasone / Generic mfg., ceftriaxone / Generic mfg.
    INFANT WITH SARS-COV-2 INFECTION CAUSING SEVERE LUNG DISEASE () -  May 19, 2022 - Abstract #ESPID2022ESPID_1360;    
    Learning Points/ This case highlights the importance of laboratory findings such as ferritin in the prediction of SARS-CoV2 infection outcome in children. Infants presenting severe COVID-19 with hyperinflammatory response require further work up for comorbidities and underlying immunodeficiencies as well as follow up for post-COVID sequelae.
  • ||||||||||  dexamethasone / Generic mfg.
    DEXAMETHASONE IN HOSPITALIZED CHILDREN WITH COVID-19: A MULTICENTER STUDY () -  May 19, 2022 - Abstract #ESPID2022ESPID_1290;    
    We observed in children with IMV who received dexamethasone, mortality was significantly lower OR: 0.033 (95% CI, 0.00 to 0.77). Regarding adverse effects in patients who received dexamethasone, insulin requirements were observed in 5(3.6%), thrombosis in 4(2.9%) and no gastrointestinal bleeding was reported.
  • ||||||||||  remdesivir / Generic mfg.
    REMDESIVIR ADMINISTRATION IN CHILDREN WITH SARS-COV-2 INFECTION: A 2-YEAR EXPERIENCE () -  May 19, 2022 - Abstract #ESPID2022ESPID_1288;    
    Fifteen patients (65.2%) had comorbidities, such as obesity (n=5, 33.3%), cardiopulmonary disease (n=3, 20%), neurologic conditions (n=3, 20%), hematologic malignancies (n=2, 13.3%), polycythemia rubra vera (n=1, 6.6%) and moderate prematurity (n=1, 6.6%). The indications for remdesivir treatment were respiratory distress with emerging need for supplemental oxygen (n=16, 69.5%), the presence of medical complexity predisposing for severe disease (n=6, 26%) and extensive pneumonia (n=1, 4.3%).
  • ||||||||||  methylprednisolone sodium succinate / Generic mfg., enoxaparin sodium / Generic mfg.
    MULTI-INFLAMMATORY SYNDROME IN CHILDREN IN SINGAPORE () -  May 19, 2022 - Abstract #ESPID2022ESPID_1246;    
    All cases were diagnosed within 2 days of hospitalization and received IVIG and intravenous methylprednisolone...Anticoagulation with enoxaparin was given to 5 patients for high D-dimer levels...While Kawasaki disease (KD) is an important differential due to similar muco-cutaneous features and increased incidence in Asian children, the above findings along with lymphopenia and thrombocytopenia, are unusual in KD. Timely diagnosis and treatment with immunomodulators, and multi-disciplinary management resulted to favourable outcomes in our patients.
  • ||||||||||  methylprednisolone sodium succinate / Generic mfg.
    CARDIAC OUTCOME AFTER SIX MONTHS IN CHILDREN WITH MIS-C () -  May 19, 2022 - Abstract #ESPID2022ESPID_1234;    
    All patient received at admission immunomodulatory treatment consisting of methylprednisolone and/or intravenous immunoglobulin...Learning Points/ A prompt treatment with immunomodulatory drugs led to a rapid recovery and no cardiac sequelae were observed. However, to date the cardiac long-term outcomes in MIS-C patients are unknown, thus a strict follow-up and larger cohorts studies are deeply needed.
  • ||||||||||  ampicillin / Generic mfg., azithromycin / Generic mfg., fluticasone / Generic mfg.
    ONCE UPON A TIME, PNEUMONIA... SARS-COV-2: GUILTY OR INNOCENT? () -  May 19, 2022 - Abstract #ESPID2022ESPID_1197;    
    Empirical antibiotic therapy was started with ampicillin and azithromycin, with no improvement in pain...He underwent a short course of oral corticosteroid therapy and was discharged home with daily inhaled fluticasone...Learning Points/ This case demonstrates the low specificity of the symptoms caused by SARS-CoV-2 in Pediatrics, as well as of the CT findings, and shows the pulmonary involvement after asymptomatic infection. The authors thus intend to draw attention to the need to share knowledge for the early recognition of this challenging disease.
  • ||||||||||  dexamethasone / Generic mfg.
    EARLY-ONSET FOCAL CEREBRAL ARTERIOPATHY IN AN INFANT WITH COVID-19 INFECTION () -  May 19, 2022 - Abstract #ESPID2022ESPID_1196;    
    Learning Points/ The early evolution of focal cerebral arteriopathy in a healthy breastfed infant is a rare manifestation of COVID-19. Early activation of the coagulation and inflammatory pathways did not manifest as multisystem inflammatory syndrome and may represent a disease spectrum determined by the balance of viremia and host innate immune response.
  • ||||||||||  remdesivir / Generic mfg., dexamethasone / Generic mfg.
    BRONCHIOLITIS AND COVID-19 IN INFANTS AND YOUNG CHILDREN: AN UNUSUAL PAIR () -  May 19, 2022 - Abstract #ESPID2022ESPID_1193;    
    Demographics are shown in Table 1. Two male infants,who presented with bronchiolitis,a 4- month and a 7-month-old, had a SARS-CoV-2 PCR(+) result on admission.
  • ||||||||||  Comirnaty (tozinameran) / Pfizer, Fosun Pharma, BioNTech
    MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN, POSSIBLE VACCINE ASSOCIATED () -  May 19, 2022 - Abstract #ESPID2022ESPID_1180;    
    He had received Pfizer/BioNTech COVID-19vaccine 2 weeks before the symptoms onset...Under the suspicion of MIS-C we started treatment intravenous methylprednisolone (1mg/kg/day) for five days...Few cases of MIS-V have recently been reported; only two reported in children. Thus, accurate statistics and pathophysiology remain unclear.
  • ||||||||||  AN UNEXPECTED CASE OF INFECTIVE ENDOCARDITIS IN A TERCIARY HOSPITAL () -  May 19, 2022 - Abstract #ESPID2022ESPID_1018;    
    Learning Points/ IE remains a diagnostic challenge, with variable clinical presentation according to the causative microorganism, pre-existing cardiac disease and complications. Our case emphasizes the subacute form associated with S. sanguis infection and the importance of a multidisciplinary team in its management.
  • ||||||||||  dexamethasone / Generic mfg., ceftriaxone / Generic mfg.
    PREVENTABLE H. INFLUENZAE MENINGITIS IN 20 MONTH-OLD UNVACCINATED PATIENT: CASE REPORT () -  May 19, 2022 - Abstract #ESPID2022ESPID_1006;    
    A cerebral CT scan showed an untreated otitis media and ethmoidal sinusitis. Serotyping of hemophilia found in the spinal fluid and blood revealed serotype type b. Learning Points/ Efforts to keep the incidence of invasive Haemophilus influenzae type B meningitis low should be directed to maintaining a high level of vaccination coverage, especially among children under 2 years of age.
  • ||||||||||  dexamethasone / Generic mfg., vancomycin / Generic mfg., ceftriaxone / Generic mfg.
    A 6-YEAR-OLD BOY WITH AN UNCOMMON CAUSE OF MENINGITIS () -  May 19, 2022 - Abstract #ESPID2022ESPID_1005;    
    SAG infections may be under-recognized, therefore special procedures for SAG detection should be provided. Interestingly, RSV infection had a rather severe course for a 6-year-old, perhaps due to preceding disease.
  • ||||||||||  ceftriaxone / Generic mfg., dexamethasone injection / Generic mfg.
    POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME: A RARE COMPLICATION OF INVASIVE PNEUMONOCOCCAL INFECTION () -  May 19, 2022 - Abstract #ESPID2022ESPID_1003;    
    Learning Points/ PRES is a rare complication of invasive pneumonococcal disease (IPD) and should be promptly recognized since it is reversible and treatable. The occurrence of IPD with serotype replacement not included in the PCV-vaccine needs further monitoring.
  • ||||||||||  dexamethasone / Generic mfg.
    HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS – WHAT A CAUSE? () -  May 19, 2022 - Abstract #ESPID2022ESPID_931;    
    Empiric antibiotics were started associated to dexamethasone...HLH has been rarely associated to congenital syphilis, only two cases reported in literature. This case also reinforces the importance of maternal serological screening during pregnancy, which may prevent severe diseases.
  • ||||||||||  dexamethasone / Generic mfg.
    Journal:  Erroneous expression of NKG2D on granulocytes detected by phycoerythrin-conjugated clone 149810 antibody. (Pubmed Central) -  May 19, 2022   
    This case also reinforces the importance of maternal serological screening during pregnancy, which may prevent severe diseases. Our results uncover an erroneous and false positive reactivity of PE-labeled (but not of APC-labeled or unconjugated) anti-NKG2D antibody 149810 on granulocytes from dexamethasone-treated GBM patients and raise a note of caution for studies of NKG2D expression on non-lymphoid cells.
  • ||||||||||  Triesence (triamcinolone acetonide injectable suspension) / Novartis
    Clinical, Journal:  Safety of intravitreal triamcinolone and its impact on optic nerve morphology in patients treated for diabetic macular edema. (Pubmed Central) -  May 19, 2022   
    To assess the impact of one intravitreal injection (IVT) of Triamcinolone Acetonide (TA) on intraocular pressure (IOP) and optic nerve structural parameters in patients treated for Diabetic Macular Edema (DME)...Our results confirmed that intravitreal TA results in IOP increase. This seems to negatively affect optic nerve morphology, even in patients without OHT or adequately treated with hypotensive agents.
  • ||||||||||  dexamethasone / Generic mfg., hydrocortisone / Generic mfg.
    Journal:  Postnatal administration of systemic steroids increases severity of retinopathy in premature infants. (Pubmed Central) -  May 19, 2022   
    Quasi-moyamoya disease can be an important phenotype of systemic vasculopathies of POEMS syndrome. By focusing on the method of systemic steroid administration and avoiding excessive doses for infants born at <28 weeks of PMA, preventing the development of severe ROP is possible.